Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|August 31, 2022
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE StudyPaul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, et al.
Blood Advances|January 19, 2018
Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophiesBrigitte T A van den Broek, Kristin Page, Annalisa Paviglianiti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2017
Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR)Melissa Gabriel, Bronwen E Shaw, Ruta Brazauskas, et al.
British Journal of Cancer|June 1, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusionsNicola C Venn, Libby Huang, Lenka Hovorková, et al.
Transplantation and Cellular Therapy|March 15, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy ConsortiumHemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, et al.
Blood Advances|March 4, 2026
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM StudyKhalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2019
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus StatementJeannine S McCune, Christine M Quinones, James Ritchie, et al.
Pageof 18